Tag Archives: patents

Janice Mueller’s New Article: Patent -Ineligible Methods of Treatment

Posted on October 12, 2015 by Warren Woessner

Patent-Ineligible Methods of Treatment Janice M. Mueller  Chisum Patent Academy October 3, 2015 Janice M. Mueller, Patent-Ineligible Methods of Treatment, in MUELLER ON PATENT LAW, VOL. I (PATENTABILITY AND VALIDITY) (Wolters Kluwer Law & Business 2012), last revised October 2015 … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | 1 Comment

USPTO Report on State of Confirmatory Genetic Testing Comes off the Waffle Iron

Posted on October 12, 2015 by Warren Woessner

In 2011—after the Fed. Cir. decision in Myriad upholding claims to BRACA1 and 2 genes—the PTO was tasked by a section of the AIA with providing Congress with a report on the effect of patenting on confirmatory genetic testing. The … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Physiology/Medicine Nobels Awarded for Discoveries of “Natural Products”

Posted on October 8, 2015 by Warren Woessner

In re Roslin Institute, a Fed. Cir. panel consisting of Judges Dyk, Moore and Wallach ruled that clones including Dolly the sheep were not patent eligible. Judge Dyk, writing for the panel endorsed the “markedly different” structure requirement for patent eligibility … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 1 Comment

Shire v. Amneal Pharma – Adjusting the Rearview Mirror

Posted on September 30, 2015 by Warren Woessner

While the IP law world is being rocked by new developments in biosimilars, patent-eligible subject matter and IPR’s, it is almost refreshing to see a decision upholding the validity of claims to a “small molecule” drug based on application of … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | 1 Comment